Vividion, Celgene partner to develop small molecule therapies

This article was originally published here

Vividion Therapeutics has partnered with Celgene to discover therapies against transformative, first-in-class targets.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply